Valeant Pharmaceuticals International

Bookmark

Add to MyYahoo RSS

Valeant Pharmaceuticals International News

News on Valeant Pharmaceuticals International (Ticker: VRX) continually updated from thousands of sources around the net.

19 hrs ago | TheStreet.com

Allergan Reiterates Plan to Preempt Valeant Offer

Allergan's remarks are not unexpected, but aggressive within the context of the takeover battle.

Comment?

Related Topix: Biotech, Valeant Pharmaceuticals International

Mon Jul 21, 2014

Benzinga

Valeant Complains to SEC Regarding Allergan Claims

Valeant Pharmaceuticals International, Inc. has contacted both the Autorite des marches financiers in Quebec and the U.S. Securities and Exchange Commission regarding Allergan Inc.'s apparent attempt to mislead investors and manipulate the market for Valeant common shares by continuing to make false and misleading statements regarding Valeant's ... (more)

Comment?

Related Topix: Allergan, Biotech, Securities and Exchange Commission, Corporate / Securities Law, Law, Valeant Pharmaceuticals International, US Securities and Exchange Commission, Financial Services

Sun Jul 20, 2014

Wall Street Journal

Big Allergan Investor Sells Most of Stake

One of Allergan Inc.'s top shareholders has sold nearly all of its holdings in the stock, leaving the Botox maker without the support of a large and long-term investor as it tries to stave off a $53 billion hostile takeover by Valeant Pharmaceuticals International Inc. and activist William Ackman.

Comment?

Related Topix: Biotech, Valeant Pharmaceuticals International

Fri Jul 18, 2014

BioSpace

Valeant Pharmaceuticals International Files Investor Presentation

The presentation includes a preview of certain results for the second quarter 2014, including 12% organic growth at Bausch + Lomb of which over 90% of the growth is due to volume increases.

Comment?

Related Topix: Biotech, Valeant Pharmaceuticals International, Securities and Exchange Commission, Corporate / Securities Law, Law

Tue Jul 15, 2014

Vision Monday

Allergan Files Investor Presentation Claiming Valeant's Business Model is 'Unsustainable'

IRVINE, Calif.- Allergan, Inc. has filed an investor presentation with the Securities and Exchange Commission that raises further concerns about what it characterizes as "potential business risks and issues" related to a proposed purchase by Valeant Pharmaceuticals International .

Comment?

Related Topix: Allergan, Biotech, Vicept Therapeutics, Valeant Pharmaceuticals International

Fri Jul 11, 2014

HAPPI/Household & PP Industry

Galderma Gains Full Rights To Distribute Restylane

Galderma S.A. has gained full rights to distribute Restylane, Perlane, Emervel, Sculptra and Dysport from Valeant Pharmaceuticals International, Inc. The expansion into aesthetic and corrective dermatology in the US and Canada completes Galderma's global skin health footprint and extends its leadership in aesthetic medicine worldwide, the company ... (more)

Comment?

Related Topix: Biotech, Valeant Pharmaceuticals International, Medicine, Dermatology

Thu Jul 10, 2014

Channelnewsasia.com

Nestle adds skincare muscle by completing Valeant deal

Swiss food giant Nestle announced Thursday that it had bolstered its hand in the medical skin treatment market by finalising a deal with Canada's Valeant Pharmaceuticals International.

Comment?

Related Topix: Biotech, Valeant Pharmaceuticals International

BioSpace

Valeant Pharmaceuticals International Completes Sale Of Filler And Toxin Assets To

Valeant Pharmaceuticals International, Inc. is a multinational specialty pharmaceutical company that develops, manufactures and markets a broad range of pharmaceutical products primarily in the areas of dermatology, eye health, neurology and branded generics.

Comment?

Related Topix: Biotech, Valeant Pharmaceuticals International

Tue Jul 08, 2014

Rochester Business Journal

B&L parent acquires PreCision Dermatology

Valeant Pharmaceuticals International Inc. has completed an acquisition of PreCision Dermatology Inc., officials said Tuesday.

Comment?

Related Topix: Biotech, Medicine, Healthcare Industry, Valeant Pharmaceuticals International, Bausch and Lomb, Medical Equipment, Rochester, NY, Allergan

BioSpace

Valeant Pharmaceuticals International Completes Acquisition Of

Valeant Pharmaceuticals International, Inc. is a multinational specialty pharmaceutical company that develops, manufactures and markets a broad range of pharmaceutical products primarily in the areas of dermatology, eye health, neurology and branded generics.

Comment?

Related Topix: Biotech, Valeant Pharmaceuticals International, Medicine, Dermatology

Mon Jul 07, 2014

Ledger-Enquirer.com

Pershing Square names Allergan board candidates

Pershing Square's Bill Ackman and Valeant Pharmaceuticals International Inc. want to buy Allergan and have offered $72 per share, or about $53 billion in cash and stock, for the company.

Comment?

Related Topix: Biotech, Valeant Pharmaceuticals International, Pharmaceutical Product Development, Medicine, Healthcare Industry

Thu Jul 03, 2014

Holtville Tribune

FTC Puts Conditions on Valeant Pharmaceuticals' Proposed Acquisition of Precision Dermatology

Valeant Pharmaceuticals International, Inc. and Precision Dermatology, Inc. have agreed to sell or relinquish rights to Precision's branded single-agent topical tretinoins and generic Retin-A, common acne treatments, to settle Federal Trade Commission charges that Valeant's proposed $475 million acquisition of Precision would likely be ... (more)

Comment?

Related Topix: Biotech, Valeant Pharmaceuticals International, Retin-A, Tretinoin (generic), Medicine

MarketWatch

The Wall Street Journal: Bausch & Lomb recalls about 850,000 tubes of eye ointment

Valeant Pharmaceuticals International Inc.'s Bausch & Lomb unit has recalled at least 850,000 tubes of an eye-care ointment because some tubes contained tiny crystal particles that could injure the cornea.

Comment?

Related Topix: Bausch and Lomb, Medicine, Medical Equipment, Healthcare Industry, Biotech, Valeant Pharmaceuticals International, Food and Drug Administration

Wed Jul 02, 2014

Hispanic Business

Valeant Files Preliminary Proxy Statement for Special Meeting of...

"Filing our preliminary proxy statement and holding a special meeting will give our shareholders a chance to show their support for our bid for is a multinational specialty pharmaceutical company that develops, manufactures and markets a broad range of pharmaceutical products primarily in the areas of dermatology, eye health, neurology and branded ... (more)

Comment?

Related Topix: Biotech, Valeant Pharmaceuticals International

Tue Jul 01, 2014

Reuters

TIMELINE-Ackman and Valeant maneuver for Allergan

Valeant Pharmaceuticals International Inc has teamed up with Pershing Square Capital Management, led by activist investor William Ackman, to make a run at Botox maker Allergan Inc. Here are the details of some of the most interesting steps along the way.

Comment?

Related Topix: Allergan, Biotech, Valeant Pharmaceuticals International

Mon Jun 30, 2014

Hispanic Business

Allergan Inc Files (8-K) Disclosing Other Events, Financial Statements and Exhibits

A copy of the presentation is attached as Exhibit 99.1 to this Current Report on Form 8-K.

Comment?

Related Topix: Biotech, Valeant Pharmaceuticals International

Fri Jun 27, 2014

Reuters

UPDATE 1-Allergan, Ackman agree special meeting won't trigger poison pill

Pershing Square Capital Management, led by activist investor William Ackman, and Allergan Inc have agreed that calling a special meeting in an effort to elect new board members will not trigger Allergan's so-called "poison pill" measure, settling a lawsuit, the companies said on Friday.

Comment?

Related Topix: Allergan, Biotech, Vicept Therapeutics, Valeant Pharmaceuticals International

Tue Jun 24, 2014

Vision Monday

Allergan Board Unanimously Rejects Valeanta s Unsolicited Takeover Bid

IRVINE, Calif.-After consulting with its independent financial and legal advisors, the board of Allergan, Inc .

Comment?

Related Topix: Allergan, Biotech, Vicept Therapeutics, Irvine, CA, Valeant Pharmaceuticals International

AmericanBankingNews.com

Insider Selling: Robert Roswell Chai-Onn Sells 10,203 Shares of...

Valeant Pharmaceuticals Intl EVP Robert Roswell Chai-Onn sold 10,203 shares of Valeant Pharmaceuticals Intl stock in a transaction dated Monday, June 23rd.

Comment?

Related Topix: Biotech, Medicine, Valeant Pharmaceuticals International, Biovail, Healthcare Industry

Wall Street Journal

Valeant CEO: Allergan Holders Support Vote on Takeover Offer

Valeant Pharmaceuticals International Inc. CEO Michael Pearson said the company is nearing its goal of rounding up enough support from Allergan Inc. shareholders to secure a vote on its $53 billion hostile bid for the Botox maker.

Comment?

Related Topix: Allergan, Biotech, Valeant Pharmaceuticals International

•••
•••
•••
•••
•••

Ashburn Jobs

•••
•••
•••
•••